Kristina Önnerhag
1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Fatty liver disease and pancreatic inflammation-A lethal combination?
2023) In United European Gastroenterology Journal(
- Contribution to journal › Article
- 2019
-
Mark
Liver-related complications and metabolic comorbidities during long-term follow-up of patients with Non-Alcoholic Fatty Liver Disease
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD)
(
- Contribution to journal › Article
-
Mark
Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities
(
- Contribution to journal › Article
-
Mark
The prediction of colorectal cancer using anthropometric measures : A Swedish population-based cohort study with 22 years of follow-up
(
- Contribution to journal › Article
-
Mark
Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis
(
- Contribution to journal › Article
- 2018
-
Mark
Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease : A double-blind, randomized, placebo-controlled study
(
- Contribution to journal › Article
- 2017
-
Mark
Waist/Hip Ratio Better Predicts Development of Severe Liver Disease Within 20 Years Than Body Mass Index : A Population-based Cohort Study
(
- Contribution to journal › Article
-
Mark
Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease
(
- Contribution to journal › Article
- 2014
-
Mark
Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD.
(
- Contribution to journal › Article